Xenon Pharmaceuticals (XENE) Stock Price, Quote, News & History | Benzinga

Xenon Pharmaceuticals Inc (XENE) Stock Price, Quote, News & History

XENENASDAQ

Trade with Public

Trade with Public

$62.35

-1.88-2.93%

At close: Aug 14, 5:00 PM EST

$62.55

0.200.32%

After Hours: Aug 14, 7:02 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$63.60

Close

$62.35

Volume / Avg.

921.88K / 1.33M

Day Range

$61.63 - $63.90

52 Wk Range

35.60 - 72.66

Market Cap

$6.05B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

5.58%

Days to Cover

7.33

Recent Xenon Pharmaceuticals Inc. News

Analyst Warns Biohaven's Lead Drug May Struggle To Stand Out

Biohaven (BHVN) shares fall as BofA downgrades the stock to Underperform, citing a risky profile ahead of key epilepsy trial data.

Vandana Singh

AutoZone To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday

Analysts change outlook on top names: Truist cut KFY price target, Oppenheimer raised AZO target, B. Riley slashed YEXT target, Stifel cut MTN target, RBC raised KNTK target, Truist cut MAA target, Wells Fargo raised XENE target, Citigroup raised HIMS target.

Avi Kapoor

Crude Oil Rises Around 4%; Xenon Pharmaceuticals Shares Surge

US stocks fell, Nasdaq down 1%, Dow down 1.71%, S&P 500 down 1.43%. Energy shares down 0.1%, consumer discretionary stocks down 2.8%. ZIM stock up after Q4 results. Autozi shares up 143%, Xenon Pharma up 41%, Hims & Hers up 38%. Silynxcom down 22%, Venu down 19%, Zeta down 16%.

Avi Kapoor

What's Going On With Biohaven Stock On Monday?

Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.

Vandana Singh

Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Higher On Monday

US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer treatment data. Hims & Hers and Xenon Pharma jump over 40%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-306.36M

Investing Cash Flow (TTM)

-223.79M

Financing Cash Flow (TTM)

958.98M

Free Cash Flow (TTM)

-307.25M

Capital Expenditure (TTM)

-889.00K

Net Change in Cash (TTM)

428.82M

Analyst Trends and Forecast

3

Feb

7

Mar

4

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.94B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

4.64

Earnings Yield % (TTM)

-7.32%

Earnings Yield % (FWD)

-6.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$13.84

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$545.87M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$63.60

Close

$62.35

Volume / Avg.

921.88K / 1.33M

Day Range

$61.63 - $63.90

52 Wk Range

35.60 - 72.66

Market Cap

$6.05B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

5.58%

Days to Cover

7.33

About

Sector

Health Care

Industry

Biotechnology

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medic...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Xenon Pharmaceuticals (XENE) stock?

A

You can purchase shares of Xenon Pharmaceuticals (NASDAQ:XENE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Xenon Pharmaceuticals (XENE) competitors?

A

Other companies in Xenon Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Xenon Pharmaceuticals (XENE) stock?

A

Xenon Pharmaceuticals has a consensus price target of $65.95.

Q

What is the current price for Xenon Pharmaceuticals (XENE)?

A

The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $62.55 last updated August 14, 2026 at 7:02 PM EDT.

Q

Does Xenon Pharmaceuticals (XENE) pay a dividend?

A

There are no upcoming dividends for Xenon Pharmaceuticals.

Q

When is Xenon Pharmaceuticals (NASDAQ:XENE) reporting earnings?

A

Xenon Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Xenon Pharmaceuticals (XENE) going to split?

A

There is no upcoming split for Xenon Pharmaceuticals.

Q

What sector and industry does Xenon Pharmaceuticals (XENE) operate in?

A

Xenon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.